Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome

  • Ryouta Maeba
  • , Hiroshi Hara
  • , Hiroshi Ishikawa
  • , Shigeru Hayashi
  • , Nakayuki Yoshimura
  • , Jyun Kusano
  • , Yoko Takeoka
  • , Daijiro Yasuda
  • , Tomoki Okazaki
  • , Makoto Kinoshita
  • , Tamio Teramoto

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience